JCR Pharmaceuticals Co., Ltd.
JCRRF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$6,414 | $5,508 | $5,412 | $19,404 |
| Dep. & Amort. | $3,374 | $3,197 | $1,997 | $1,945 |
| Deferred Tax | $0 | $0 | -$9,221 | -$3,074 |
| Stock-Based Comp. | $9 | $71 | $173 | $177 |
| Change in WC | -$74 | -$6,055 | -$2,956 | -$9,030 |
| Other Non-Cash | -$2,381 | $6,591 | -$905 | -$133 |
| Operating Cash Flow | -$5,486 | $9,312 | -$5,500 | $9,289 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$9,888 | -$2,095 | -$8,560 | -$11,333 |
| Net Acquisitions | $145 | -$600 | -$6,717 | $8,167 |
| Inv. Purchases | $0 | $0 | -$906 | -$300 |
| Inv. Sales/Matur. | $0 | $0 | $259 | $300 |
| Other Inv. Act. | -$131 | $5 | $922 | -$84 |
| Investing Cash Flow | -$9,874 | -$2,690 | -$15,002 | -$3,250 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $14,805 | $500 | $4,700 | $0 |
| Stock Issued | $0 | $0 | $0 | $0 |
| Stock Repurch. | -$2,530 | $15 | $10 | $10 |
| Dividends Paid | -$2,505 | -$2,500 | -$2,739 | -$2,169 |
| Other Fin. Act. | -$55 | -$46 | -$23 | -$20 |
| Financing Cash Flow | $9,736 | -$2,031 | $1,948 | -$2,179 |
| Forex Effect | $64 | $886 | $1,099 | $612 |
| Net Chg. in Cash | -$5,560 | $5,478 | -$17,455 | $4,473 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $18,756 | $13,278 | $30,733 | $26,260 |
| End Cash | $13,196 | $18,756 | $13,278 | $30,733 |
| Free Cash Flow | -$15,374 | $7,217 | -$14,060 | -$2,044 |